[Evaluation of pituitary gonadotropin fractions (TG, FSH, LH) and ovarian as well as adrenocortical urinary metabolites in menopausal women with congenital or acquired absence of ovaries and polycystic ovarian degeneration syndrome].
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002369:Castration; D005260:Female; D006065:Gonadotropins, Pituitary / Q000652:urine*; D006801:Humans; D008593:Menopause; D008598:Menstruation; D008875:Middle Aged; D010053:Ovary / Q000002:abnormalities*; D011085:Polycystic Ovary Syndrome / Q000652:urine*; D014424:Turner Syndrome / Q000652:urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D006065:Gonadotropins, Pituitary
Ocena wydalania frakcji gonadotropin przysadkowych (TG, FSH, LH), i metabolitów sterydów jajnikowych i korowo-nadnerczowych w moczu u kobiet w okresie menopauzy, z wrodzonym i nabytym brakiem jajników oraz z ich torbielkowatym zwyrodnieniem